Earnings Feed
Start Free
RESMED INC·4

Sep 3, 5:39 PM ET

Sandercock Brett 4

4 · RESMED INC · Filed Sep 3, 2025

Insider Transaction Report

Form 4
Period: 2025-09-02
RESMED INCRMD
Sandercock Brett
Chief Financial Officer
Transactions
  • Exercise/Conversion

    ResMed Common Stock

    [F1]
    2025-09-02$101.64/sh+2,000$203,280→ 90,745 total
  • Sale

    ResMed Common Stock

    [F1]
    2025-09-02$270.77/sh−3,000$812,310→ 87,745 total
  • Exercise/Conversion

    ResMed Common Stock Options

    [F2]
    2025-09-02−2,000→ 4,000 total
    Exercise: $101.64From: 2019-11-11Exp: 2025-11-14→ ResMed Common Stock (2,000 underlying)
Footnotes (2)
  • [F1]The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.
  • [F2]Represents date options first become exercisable. Options vest 1/3 per year.
Signature
Brett Sandercock, Chief Financial Officer|2025-09-03

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT